We’re excited to share that members of the Bayer Lab are presenting their research at the Southeastern Immunology Symposium (SIS) in Asheville, North Carolina, this week. Allison Bayer, PhD, will present “Reprogramming Autoimmunity: Antigen-Specific Treg Strategies for Durable Tolerance in Type 1 Diabetes”. Rutuparnna Mishra will present a poster entitled, “Antigen-specific Regulatory T Cell Therapy Mode-of-Action in Controlling Autoimmune Type 1 Diabetes”, and Emerson Parks will present a poster entitled, “Antigen-Specific Treg Therapy Enhances Immunomodulatory Pathways in Autoimmune Diabetes”. These presentations highlight ongoing efforts to develop antigen-specific regulatory T cell (Treg) therapies aimed at restoring immune tolerance and improving outcomes for individuals with Type 1 Diabetes. Congratulations to Allison, Rutuparnna, and Emerson on representing the Bayer Lab and sharing their work with the immunology research community!